This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Eidos Therapeutics, Inc., Kronos Bio, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I am here to help you with the article about inventor Jesper Alexis Jernelius.
Title: Jesper Alexis Jernelius - A Silicon Valley Innovator
Introduction:
Jesper Alexis Jernelius is a talented inventor based in San Francisco, CA (US). With a passion for creating cutting-edge solutions, he has made significant contributions to the field of pharmaceuticals.
Latest Patents:
1. Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors - This patent focuses on polymorphs of a bis-mesylate salt of a compound with specific formulations and methods of use.
2. Formulations of AG10 - Jernelius's latest patent showcases high-load tablet formulations of AG10, emphasizing the inclusion of pharmaceutical excipients for enhanced efficacy.
Career Highlights:
Jesper Alexis Jernelius has worked with reputable companies such as Kronos Bio, Inc. and Eidos Therapeutics, Inc. His expertise and innovative mindset have played a crucial role in the success of these organizations in advancing pharmaceutical technologies.
Collaborations:
Throughout his career, Jernelius has collaborated closely with industry experts like Tim G Elford and Peter Chee-Chu Fung. These collaborations have not only enriched his professional experience but also led to groundbreaking inventions in the pharmaceutical sector.
Conclusion:
In conclusion, Jesper Alexis Jernelius stands out as a visionary inventor in Silicon Valley, with a remarkable track record of patenting innovative pharmaceutical solutions. His dedication to pushing the boundaries of science and technology continues to inspire the next generation of inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile